CAPD versus haemodialysis: a comparison in the same patients

Area of Science:

• Nephrology
• Internal Medicine
• Renal Replacement Therapy

Background:

• Previous comparisons of Continuous Ambulatory Peritoneal Dialysis (CAPD) and hemodialysis (HD) often involved different patient populations.
• Matching for sex and age is crucial for accurate therapeutic comparisons in end-stage renal failure (ESRF) management.

Purpose of the Study:

• To directly compare the clinical and biochemical effects of CAPD and HD in a single group of non-diabetic ESRF patients.
• To evaluate differences in hemoglobin, blood transfusion needs, serum creatinine, BUN, potassium, calcium, cholesterol, and hospitalization rates between CAPD and HD therapies.

Main Methods:

• A cohort of 13 non-diabetic ESRF patients underwent both CAPD and HD therapies for a minimum of six months each.
• Longitudinal analysis of biochemical markers and clinical outcomes was performed for each treatment modality.

Main Results:

• Patients exhibited higher hemoglobin and serum cholesterol levels during CAPD compared to HD.
• Serum creatinine, BUN, and potassium were lower with CAPD, while serum calcium was higher during HD.
• Cholesterol levels normalized within four months of switching from CAPD to HD.
• Hospitalization rates were comparable between the two treatment groups.

Conclusions:

• CAPD and HD present distinct biochemical profiles in ESRF patients, notably affecting hemoglobin, lipids, and electrolytes.
• Despite biochemical differences, hospitalization rates were similar, suggesting comparable efficacy in terms of major adverse events.
• The findings support previous studies that used sex- and age-matched comparisons for CAPD and HD.